GE11‐Modified Red Blood Cell Membrane Nanoprodrug for ROS‐Responsive Synergistic Photothermal–Chemotherapy of Esophageal Cancer
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing University, Chongqing, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Reactive Oxygen Species, Nanoparticles, Prodrugs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, China Postdoctoral Science Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Esophageal cancer (EC) remains a highly aggressive malignancy with limited therapeutic options and poor prognosis. To address the shortcomings of conventional therapies, we developed a biomimetic, reactive oxygen species (ROS)‐responsive nanoprodrug for synergistic photothermal–chemotherapy of EC. Tannic acid and ellagic acid were chemically linked via boronate ester bonds to form a polyphenol‐based nanoparticle (TPE). The epidermal growth factor receptor (EGFR)‐targeting peptide GE11 was subsequently introduced onto red blood cell membranes (RBCM) to obtain GE11‐RBCM, which was then used to cloak the TPE nanoparticles, yielding GE11‐RBCM@TPE. The resulting nanoplatform exhibited excellent photothermal conversion capability under near‐infrared irradiation and selectively released the therapeutic payload in response to elevated ROS levels within the tumor microenvironment. In vitro studies showed enhanced cellular uptake in EGFR‐overexpressing EC cells and markedly increased cell death following combined photothermal and chemotherapeutic treatment. In vivo, GE11‐RBCM@TPE significantly inhibited tumor growth with negligible systemic toxicity and prolonged blood circulation. Transcriptomic analysis further revealed up‐regulation of pro‐apoptotic ( PER1 , HK2 , BMF , DAPK2 ) and autophagy‐related genes ( ATP6V0D2 , HDAC10 , BNIP3 , DEPP1 , ATG9B , NAT16 ), while SQSTM1 and IL6 were down‐regulated, indicating simultaneous activation of apoptosis and autophagy. These findings suggest that GE11‐RBCM@TPE represents a promising strategy for precise and effective treatment of esophageal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing University, Chongqing, China.
- Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing University, Chongqing, China.
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing, China.
- Department of Anesthesiology, Chongqing University Cancer Hospital, Chongqing, China.
ORCID-Profile: Zhiqiang Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- China Postdoctoral Science Foundation
- Chongqing Postdoctoral Special Funding
- Chongqing Science and Health Joint Traditional Chinese Medicine Research Project
- Special Project for Scientific Research of Chongqing University Cancer Hospital
- Open Project of the Key Laboratory of the Municipal Health Commission for Medical Science Research (Joint Program of Science and Health) and Scientific and Tec…
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Chen, Y., Zhu, L., Xu, W., Chen, Q., Teng, F., Bao, K., Zhang, L., Wang, Y., Wu, W., & Wang, Z. (2026). GE11‐Modified Red Blood Cell Membrane Nanoprodrug for ROS‐Responsive Synergistic Photothermal–Chemotherapy of Esophageal Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504376
Vancouver
Chen Y, Zhu L, Xu W, Chen Q, Teng F, Bao K, et al. GE11‐Modified Red Blood Cell Membrane Nanoprodrug for ROS‐Responsive Synergistic Photothermal–Chemotherapy of Esophageal Cancer. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504376
BibTeX
@article{Chen2026,
author = {Chen, Yang and Zhu, Li and Xu, Wei and Chen, Qi and Teng, Fei and Bao, Kaiwen and Zhang, Lu and Wang, Yuan and Wu, Wei and Wang, Zhiqiang},
title = {GE11‐Modified Red Blood Cell Membrane Nanoprodrug for ROS‐Responsive Synergistic Photothermal–Chemotherapy of Esophageal Cancer},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504376}
}
EUVIMED